Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2010
Title: The Innovative Contributions of Gongqin Sun
Introduction
Gongqin Sun is a notable inventor based in Wakefield, Rhode Island. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents targeting protein tyrosine kinases. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this specialized area.
Latest Patents
Gongqin Sun holds a patent titled "Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents." This patent describes a bisubstrate inhibitor of Src kinases, which includes a nucleotide or N-heteroaromatic moiety and a peptide/phosphopeptide, peptidomimetic, or phosphopeptide mimic moiety. The moieties are linked by either a rigid or flexible linker. The nucleotide or N-heteroaromatic moiety can be ATP, ATP-mimics, or various N-heteroaromatics, including purine-based and pyrimidine-based derivatives. The phosphopeptide mimics consist of phosphonate-based and carboxylic acid-based phosphotyrosine mimetics, which inhibit the Src kinases SH2 domain. Gongqin Sun's patent represents a significant advancement in therapeutic strategies for diseases related to protein tyrosine kinases.
Career Highlights
Throughout his career, Gongqin Sun has worked with various organizations, including the Board of Governors for Higher Education and the State of Rhode Island and Providence Plantations. His experience in these institutions has allowed him to contribute to educational and research initiatives that promote innovation in the scientific community.
Collaborations
Gongqin Sun has collaborated with notable colleagues, including Keykavous Parang and Anil Kumar. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Gongqin Sun's contributions to the field of biochemistry and his innovative patent demonstrate his commitment to advancing therapeutic solutions. His work continues to inspire future research and development in the area of protein tyrosine kinases.